Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations

Abstract Coronavirus disease 2019 (COVID-19) is the third coronavirus outbreak that has emerged in the past 20 years, after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). One important aspect, highlighted by many global health organizations, is that this novel coronavirus outbreak may be especially hazardous to healthcare personnel, including laboratory professionals. Therefore, the aim of this document, prepared by the COVID-19 taskforce of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), is to provide a set of recommendations, adapted from official documents of international and national health agencies, on biosafety measures for routine clinical chemistry laboratories that operate at biosafety levels 1 (BSL-1; work with agents posing minimal threat to laboratory workers) and 2 (BSL-2; work with agents associated with human disease which pose moderate hazard). We believe that the interim measures proposed in this document for best practice will help minimazing the risk of developing COVID-19 while working in clinical laboratories.

[1]  Neurological manifestations associated with COVID-19: a review and a call for action , 2020, Journal of Neurology.

[2]  T. Baggett,et al.  Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston. , 2020, JAMA.

[3]  G. Lippi,et al.  Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019 , 2020, Mayo Clinic Proceedings.

[4]  E. Dean.  COVID-19: infection prevention and control advice for all healthcare settings , 2020, Learning Disability Practice.

[5]  Charles A. Morris,et al.  Universal Masking in Hospitals in the Covid-19 Era. , 2020, The New England journal of medicine.

[6]  Qing-Xia Ma,et al.  Potential utilities of mask‐wearing and instant hand hygiene for fighting SARS‐CoV‐2 , 2020, Journal of medical virology.

[7]  T. Greenhalgh.  What is the efficacy of standard face masks compared to respirator masks in preventing COVID-type respiratory illnesses in primary care staff? , 2020 .

[8]  Edward Livingston,et al.  Sourcing Personal Protective Equipment During the COVID-19 Pandemic. , 2020, JAMA.

[9]  G. Iacobucci,et al.  Covid-19: Lack of PPE in care homes is risking spread of virus, leaders warn , 2020, BMJ.

[10]  M. J. Broadhurst,et al.  Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center , 2020, medRxiv.

[11]  Y. Leo,et al.  Absence of contamination of personal protective equipment (PPE) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) , 2020, Infection Control & Hospital Epidemiology.

[12]  Carl A. B. Pearson,et al.  The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study , 2020, The Lancet Public Health.

[13]  Megan L Ranney,et al.  Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic. , 2020, The New England journal of medicine.

[14]  Giuseppe Lippi,et al.  Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm , 2020, Annals of translational medicine.

[15]  M. Day.  Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village , 2020, BMJ.

[16]  M. Cascella,et al.  Features, Evaluation and Treatment Coronavirus (COVID-19) , 2020 .

[17]  B. Cowling,et al.  Rational use of face masks in the COVID-19 pandemic , 2020, The Lancet Respiratory Medicine.

[18]  G. Lippi,et al.  The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks , 2020, Clinical chemistry and laboratory medicine.

[19]  A. Bowdle,et al.  Preventing Infection of Patients and Healthcare Workers Should Be the New Normal in the Era of Novel Coronavirus Epidemics , 2020, Anesthesiology.

[20]  L. Poon,et al.  Stability of SARS-CoV-2 in different environmental conditions , 2020, The Lancet Microbe.

[21]  Dylan H. Morris,et al.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 , 2020, The New England journal of medicine.

[22]  G. Kampf,et al.  Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols , 2020, bioRxiv.

[23]  E. Holmes,et al.  The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.

[24]  Elisabeth Mahase.  Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction , 2020, BMJ.

[25]  Jie Hao,et al.  Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection , 2020, Frontiers of Medicine.

[26]  R. Lu,et al.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.

[27]  Tobias Bleicker,et al.  Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster , 2020, medRxiv.

[28]  B. Cowling,et al.  Respiratory virus shedding in exhaled breath and efficacy of face masks , 2020, Nature Medicine.

[29]  A. M. Leontovich,et al.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.

[30]  Tai Hing Lam,et al.  Mass masking in the COVID-19 epidemic: people need guidance , 2020, The Lancet.

[31]  P. Klepac,et al.  Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts , 2020, The Lancet Global Health.

[32]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[33]  Taiwen Li,et al.  High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa , 2020, International Journal of Oral Science.

[34]  Min Kang,et al.  SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.

[35]  G. Kampf,et al.  Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents , 2020, Journal of Hospital Infection.

[36]  Federico M Giorgi,et al.  Genomic variance of the 2019‐nCoV coronavirus , 2020, Journal of medical virology.

[37]  Mi Seon Kim,et al.  Identification of Coronavirus Isolated from a Patient in Korea with COVID-19 , 2020, Osong public health and research perspectives.

[38]  [Infection prevention and control for COVID-19 in healthcare settings]. , 2021, Uirusu.

[39]  Alexandria C Brown,et al.  N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial. , 2019, JAMA.

[40]  E. Lazartigues,et al.  Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function , 2010, Current hypertension reports.

[41]  P. Teunis,et al.  Professional and Home-Made Face Masks Reduce Exposure to Respiratory Infections among the General Population , 2008, PloS one.

[42]  Y. Li,et al.  How far droplets can move in indoor environments--revisiting the Wells evaporation-falling curve. , 2007, Indoor air.

[43]  E Newton,et al.  In vivo protective performance of N95 respirator and surgical facemask. , 2006, American journal of industrial medicine.

[44]  A. Hubbard,et al.  Toward Understanding the Risk of Secondary Airborne Infection: Emission of Respirable Pathogens , 2005, Journal of occupational and environmental hygiene.

[45]  Tze Wai Wong,et al.  Evidence of airborne transmission of the severe acute respiratory syndrome virus. , 2004, The New England journal of medicine.